The damage of the skeletal muscle prompts a complex and coordinated response that involves the interactions of many different cell populations and promotes inflammation, vascular remodeling and finally muscle regeneration. Muscle disorders exist in which the irreversible loss of tissue integrity and function is linked to defective neo-angiogenesis with persistence of tissue necrosis and inflammation. Here we show that macrophages (MPs) are necessary for efficient vascular remodeling in the injured muscle. In particular, MPs sustain the differentiation of endothelial-derived progenitors to contribute to neo-capillary formation, by secreting pro-angiogenic growth factors. When phagocyte infiltration is compromised endothelial-derived progenitors undergo a significant endothelial to mesenchymal transition (EndoMT), possibly triggered by the activation of transforming growth factor-b/bone morphogenetic protein signaling, collagen accumulates and the muscle is replaced by fibrotic tissue. Our findings provide new insights in EndoMT in the adult skeletal muscle, and suggest that endothelial cells in the skeletal muscle may represent a new target for therapeutic intervention in fibrotic diseases.
The homeostatic response of skeletal muscle to injury involves various cell populations. After acute injury, the initial phase of muscle repair is characterized by necrosis of the tissue and activation of an inflammatory response.
1,2 Growth factors and inflammatory cytokines released by infiltrating leukocytes lead to the activation of cells, which have the capacity to reconstitute the damaged muscle and promote re-vascularization of the tissue.
Progenitors in the muscle comprise the satellite cells, which are the primary myogenic stem cells responsible for skeletal muscle regeneration after damage, 3 and vessel-associated progenitors. 4 Vascular progenitors contribute to muscle regeneration by induction of new vessels, therefore increasing tissue perfusion and oxygenation, and through differentiation in muscle fibers. 5 Angiogenesis and myogenesis take place simultaneously during muscle regeneration: endothelial cells control both myogenic cell growth and quiescence. Conversely, myogenic cells increase angiogenesis. [6] [7] [8] Macrophages (MPs) are the major infiltrating population in injured muscle. Their functions during muscle regeneration and the mechanisms and the molecules involved have been only partially elucidated. At least two distinct MP populations exist. Classically activated inflammatory MPs express high levels of molecules involved in T-cell activation and costimulation while alternatively activated MPs express high levels of scavenger receptors. [9] [10] [11] [12] The phagocytosis of muscle debris modulates the response of muscle to acute injury, promoting the switch of classically activated toward alternatively activated MPs, an event that contributes to myogenesis 13 and might have a role in the recruitment and differentiation of vascular-associated progenitors. 14, 15 Vessels failing to assemble and a jeopardized angiogenesis concur to muscle wasting; 7, 16 these might depend on a primitive defect of endothelial progenitors or on defective signaling necessary for their survival, proliferation or differentiation. The loss of endothelial identity in favor of a mesenchymal phenotype can also lead to tissue disorganization and fibrosis. 17 This phenomenon, referred to as endothelial to mesenchymal transition (EndoMT), has been proposed to exacerbate the severity of many different diseases, still has not been described in the skeletal muscle.
Here we have investigated the fate of postnatal endothelial progenitors using a transgenic lineage-tracing approach and verified that MP infiltration is necessary for the differentiation of endothelial-derived progenitors, while inhibiting EndoMT and subsequent fibrosis.
Results
Postnatal VE-Cadherin þ derived cells differentiate to endothelial cells in growing and adult skeletal muscle. We have investigated angiogenesis and the fate of postnatal endothelial progenitors in the adult skeletal muscle, by taking advantage of transgenic mice expressing a tamoxifen (TAM)-inducible form of Cre recombinase (CRE-ER T2 ) under the control of the endothelial-specific gene VE-Cadherin (VE-Cad) regulatory sequences, Cdh5-CreER T2 . 18 These mice were crossed with the reporter mice R26R-enhanced yellow fluorescent protein (EYFP) 19 or R26R-NZG 20 and Cre recombination was induced in double transgenic mice by TAM injection at stages P6-P7-P8, thus labeling postnatal VE-cadherin-expressing cells.
To verify the specificity of labeling, tibialis anterior (TA), quadriceps or triceps muscles were retrieved immediately after the induction (72 h) or in adult mice (60 days). At both times, the majority of EYFP þ or b-galactosidase þ (b-Gal þ ) cells expressed the endothelial marker CD31 (100% at 72 h, 93% ± 6.6 at P60; Figure 1a , Supplementary Figure S1) . Only rare cells co-expressed a-smooth muscle actin (SMA) or neural/glial antigen 2 (NG2) markers of mesenchymal cells, such as smooth muscle and pericytes (o4 ± 2.4% at P60). Consistently, EYFP þ cells isolated by fluorescence-activated cell sorting (FACS) from muscles of Cdh5-CreER T2 ;R26R-EYFP mice, 72 h and 60 days after TAM injection (Figure 1b) , mainly expressed endothelial transcripts (VE-Cad and CD31), even if expression of mesenchymal genes (in particular a-SMA and a lower extent c/EBP, PDGFR-b) and of some hematopoietic-specific transcripts (CD45, CD90) was detectable (Figure 1c ). This suggests potency for mesenchymal differentiation. No myogenic-specific transcripts were expressed. These results indicate that the postnatal endothelial progenitors primarily differentiate into endothelial cells in the muscle.
Capillary network formation upon muscle damage parallels the modulation of MP-specific angiogenic and matrix remodeling factors. To investigate angiogenesis and the fate of endothelial progenitors during muscle regeneration, we elicited an acute sterile damage in 2 months old Cdh5-CreER T2 ;R26R-EYFP or R26R-NZG (after postnatal Cre induction) by injecting cardiotoxin (CTX) in the TA, quadriceps or triceps muscles. Injured and uninjured muscles were collected 1, 3, 5, 7, 10 and 15 days after injury.
We analyzed vessel organization by CD31 immunofluorescence (IF) on TA muscles sections. Three days after damage, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay showed massive death of CD31 þ cells (Supplementary Figure S3) . Two days later, we observed the presence of single CD31 þ cells not assembled anymore in capillary vessels. Reorganization in vessels started soon after and was completed by day 15 (Figure 2a) . At all times, EYFP þ or b-Gal þ endothelial-derived progenitors co-expressed at high frequency the endothelial marker CD31, demonstrating that they contribute to the revascularization of the tissue (Figure 2a, Supplementary  Figure S1 ).
Vessel remodeling was accompanied by the modulation of the expression of specific cytokines and angiogenic factors, as assessed by quantitative real-time PCR (qPCR) analysis or western blot on total muscle lysates ( Figure 2b ). As a consequence of hypoxia, levels of angiopoietin II (Ang-II) and hypoxia-inducible factor 1 alpha (HIF-1a) increased immediately after damage, at RNA and protein levels. Ang-II may contribute to trigger angiogenesis soon after in conjunction with vascular endothelial growth factor-b (VEGF-b). Transforming growth factor-b (TGF-b), platelet-derived growth factor-a (PDGF-a) and b also peaked soon after damage. The drop in expression of VEGF-b and Ang-I immediately after injury is possibly due to death of endothelial cells and the disassembly of the capillary network. Expression of metalloproteases (MMPs) was also modulated. MMP2, MMP13 and MMP14 levels increased 3 days after damage and persisted till day 15; remodeling and maintenance of the extracellular matrix (ECM) is indeed required for effective tissue healing (Figure 2b) .
To investigate the role of infiltrating MPs recruited at the site of damage as a source of molecules responsible for the vascular and matrix remodeling, we isolated CD11b þ MPs from the muscle 1, 3, 5, 7 and 10 days after CTX injection and performed qPCR and/or western blot analysis. Circulating CD11b þ cells from untreated mice were used as positive control. HIF-1a accumulated immediately after injury both at mRNA and protein levels (Figure 2c) . Consistently, MP expression of angiogenic factors, such as PDGF-a and b and VEGF increased during regeneration. TGF-b was persistently expressed throughout tissue remodeling (Figure 2c ). Ang-II expression was bimodal, with peaks immediately and 10 days after damage. Ang-I was consistently limited. Infiltrating CD11b þ cells highly expressed MMP13 and MMP14 soon after damage and throughout the healing process. MMP2 was expressed by MPs during the late phases of muscle regeneration with a peak around day 10, consistently with the proposed involvement of MMP2 in the degradation of collagen IV of the basement membrane during myoblast proliferation, migration and fusion. 21 As previously reported, we confirmed that cytokines expression was modulated during the response to injury. Interleukin-10 (IL-10) peaked at day 3 after injury and its Figures S4B  and C) .
The depletion of MPs resulted in a delay in fiber regeneration (Supplementary Figure S4D) and hampered the vascular remodeling of the tissue, as indicated by immunohistochemistry (IHC) analysis for CD31 (Figure 3a) . In MP-depleted mice, the neovasculature was disorganized and jeopardized: between 5 and 10 days after damage, number and area of capillaries both in TA and triceps ( Figure 3a) were significantly reduced. Notably, 10 days after damage TA muscles of MP-depleted mice comprised a relatively high number of capillaries (Figure 3b ). However, vessels were mostly isolated and showed a striking reduction of the lumen diameter (Figure 3c ). At day 15, vascular remodeling was complete in muscles of both sham-treated and MP-depleted animals ( Figure 3 ). To get insights into the fate of these CD31 À EYFP þ endothelial-derived progenitors in MP-depleted muscle, we measured the expression of different cell-specific markers.
EndoMT has been described to occur in several tissues, still never in skeletal muscle. These results suggest that in the absence of MPs EndoMT is occurring.
Among the mesenchymal progenitor cells that reside in the muscle, PDGFR-a þ fibroadipogenic progenitors (FAPs) have been described to expand upon muscle damage and to contribute to fibrosis and fat accumulation in ageing and disease. [26] [27] [28] In Cll-treated mice, we observed the expected accumulation of interstitial PDGFR-a þ cells at 3-7-10 days after CTX damage: their number was always similar to sham-treated mice (Supplementary Figure S5) , indicating FAPs expansion is not affected by phagocyte depletion. In addition, we did not observed colocalization of EYFP or b-Gal with PDGFRa, thus endothelial-derived progenitors do not differentiate into FAP (Supplementary Figure S5) .
In conditions in which inflammatory phagocytes did not deliver appropriate signals to progenitor cells within the regenerating muscle, we therefore observed that endothelialderived progenitors underwent EndoMT and contributed to the uncontrolled expansion of fibroblast/mesenchymal cells, ultimately leading to collagen accumulation. Indeed, 21 days after damage, muscles were characterized by non-homogenous regenerating fibers surrounded by large areas of fibrosis and fat, while muscles of sham-treated mice were devoided of fibrosis and showed complete regeneration (Figures 6a and b) .
MP depletion affects angiogenic and fibrogenic signaling. To get insights into the mechanism through which infiltrating MPs restrict EndoMT, we analyzed the expression of growth factors, cytokines, proteases and chemokines in the healing muscle from day 5, a time after which we start observing mesenchymal transition of endothelial progenitors (Figures 7a-c) . Upon MPs depletion, HIF1-a mRNA levels were increased and Ang-II expression was still upregulated at day 7, probably due to the persistence of hypoxia. In contrast, the expression of VEGF, PDGF-a PDGF-b, IL-10 and TNF-a was downregulated at all times (Figure 7a and Supplementary Figure S2) .
Expression of MMP2, MMP13 and MMP14 between 5 and 15 days after injury was reduced in Cll-treated mice in agreement with an inefficient fibrolitic activity (Figure 7b) .
TGF-b/bone morphogenetic protein (BMP)/SMAD signaling is the main pathway implicated in EndoMT. 29, 30 We detected no significant differences in the expression of BMP-2 and BMP-4 in MP-depleted mice with respect to controls, while BMP-6 appeared to be overexpressed in Cll-treated mice 15 days after damage (Supplementary Figure S6) . TGF-b mRNA expression was lower at 5 and 10 days after injury, while at 7 days there was no difference between Cll-treated and control mice (Figure 7c) . Conversely, the levels of TGF-b-activated protein was markedly upregulated 5 and 7 days after injury (Figure 6c) , correlating with the onset of EndoMT. Interestingly Snail, a downstream target of TGF-b signaling, was upregulated in MP-depleted muscles 5 and 10 days after damage (Figure 7a) .
IF analysis using a phosphoSMAD2/3-specific antibody revealed an increased frequency of EYFP þ endothelialderived progenitors showing SMADs nuclear activity, in the muscle of Cll-treated mice (Figures 7b and c) indicating that the TGF-b/SMAD signaling was specifically activated in endothelial-derived progenitor in the absence of MPs.
Discussion
The accumulation of fibrogenic cells is responsible for the production of ECM during the establishment of fibrosis in various degenerative diseases. The origin of these cells is still poorly understood. Here we demonstrate that in damaged skeletal muscle endothelial-derived progenitors can generate Muscle damage triggers a series of coordinated events aimed at remodeling and healing of the tissues. These comprise the recruitment of inflammatory cells that first clear the debris, then contribute to the activation and differentiation of the muscle stem cells and their fusion in new myofibers. 31 Neo-angiogenesis is also necessary to establish a new vascular network. Another crucial component required to sustain and act as scaffold for the new myofiber formation is the ECM that is first derived from the necrotic fibers and subsequently secreted from the myofibroblasts that proliferate in situ or migrate in the healing muscle. 32 Perturbation of any of these steps can result in an ineffective muscle healing, typically characterized by persistent myofiber degeneration, inflammation and fibrosis, resulting from a excessive accumulation of ECM components. 33 By using an endothelial-specific lineage-tracing mouse model, we followed the fate of endothelial progenitors during muscle regeneration after an acute injury. In physiological condition, when polarized MPs infiltrate the tissue, the vast majority of these endothelial-derived cells contribute to the formation of a new capillary network. When we perturbed this process, by depleting circulating monocytes and infiltrating MPs, we observed delayed angiogenesis and myogenesis. In addition, the accumulation of infiltrating fibroblasts and collagen did not abate as regeneration occurred, leading to a persistent fibrosis.
Expression profile of candidate factors in MP-depleted muscle indicated that one of the possible cause of unremitting collagen accumulation is the decreased level of some MMPs. 21 In particular, MMP13 has been described to be expressed not only by MPs but also by migrating fibroblasts and muscle satellite cells during skeletal muscle regeneration, and its persistent expression during all phases of regeneration suggests a dual role in supporting cell movements and tissue healing as well as in long-term collagen remodeling and scar reduction. 34 A similar effect of MMP14 (MT1-MMP1) and MMP2 can be envisaged. 33 Mice deficient in the cell-associated MMP-MT1 exhibited smaller and centrally nucleated myofibers compared with normal mice, and treatment with active MT1-MMP can effectively reduce muscle scarring. 35, 36 The decreased expression of MMP13, MMP14 and MMP2 in Cll-treated mice, due to decrease production from MPs and muscle cells, could correlate with the delay in regeneration and collagen deposition.
Collagen accumulation is also due to the increased amount of resident fibroblasts/mesenchymal progenitor cells. In addition, quiescent FAPs represent a significant fraction of fibrogenic cells in adult skeletal muscle. 26, 27 FAP population did indeed expand upon muscle damage, to decline afterward, but their number was not affected by MP depletion, in agreement with the fact that they are regulated by eosinophils and not by MPs. 37 Moreover, we demonstrated that FAPs do not show lineage continuity with endothelial-derived progenitors.
In Cll-treated mice, endothelial-derived progenitors appeared to contribute markedly less to capillary formation and neo-angiogenesis, possibly exacerbating the delay in these processes. More crucially, they downregulated the expression of endothelial markers, whereas upregulating mesenchymal markers, including collagen I. In particular, from day 7 after damage in Cll-treated mice, we observed approximately the doubling of b-Gal cells expressing NG2/a-SMA while being negative for CD31, with respect to controls, suggesting that EndoMT is occurring. Although in the past, EndoMT was believed to be a rare phenomenon confined to embryonic development, its existence in the adult vasculature has been reported. Recent studies have demonstrated that EndoMT may be an important mechanism in the pathogenesis of pulmonary, cardiac, kidney fibrosis, and in the onset and progression of cerebral cavernous malformations, and may represent a novel therapeutic target for fibrotic disorders. 24, 25, 29, 38, 39 To our knowledge, this is the first description of EndoMT occurring in the adult skeletal muscle and may concur to the severity of many degenerative diseases, including muscular dystrophy.
In contrast to epithelial to mesenchymal transition (EMT), very few studies have addressed the molecular mechanisms underlying EndoMT. TGF-b signaling has a crucial role in the transformation of mouse embryonic stem cell-derived endothelial cells or human dermal microvascular endothelia into cells that express mesenchymal markers (a-SMA, SM22a and calponin) and loose/co-express endothelial markers. 30, 40 In our conditions, BMPs mRNA levels were not affected by MP depletion except at later stages: BMP-6 increase in Cll-treated mice 15 days after damage could be a late secondary effect, since at this time fibrosis is already in progress and EndoMT has already occurred. Transcript levels of PDGF-a and b, factors also associated with fibroblasts activation and differentiation, 32 were reduced as well as those of TGF-b. Interestingly, MP-depleted muscle contains higher levels of TGF-b-activated protein. Circulating inflammatory cells or mesenchymal cells have been proposed to be the source of TGF-b. 17 In our model of MP depletion, the upregulation or increased release of TGF-b protein has to be mediated by other cell types, as a secondary effect of the impaired signaling from inflammatory phagocytes.
Snail, a downstream target of TGF-b/BMP pathway and required for EndoMT 30 was consistently upregulated in muscles of Cll-treated mice. In these mice, nuclear pospho SMAD2/3 was found specifically in endothelial-derived progenitors, suggesting that EndoMT is triggered by the TGF-b /BMP cascade.
Ang-II can also be implicated into this pathway and in fibrosis both in a TGF-b-dependent and -independent manner: it can influence not only TGF-b production, but also lead to the nuclear translocation of phosphorylated SMADs. 32, 41 Ang-II expression was indeed increased in muscle of Cll-treated mice 7 days after damage, at the onset of the expansion of the endothelial-derived mesenchymal cells. In these mice, capillary network formation is delayed, and persistent hypoxia may contribute to the upregulation of Ang-II and consequently of HIF-1a. It is plausible that the SMAD-dependent EndoMT may be therefore also caused by direct or indirect activation of the pathway by hypoxiainduced signals.
Direct interference with Ang-II or treatment with TGF-b neutralizing antibodies may clarify their specific role in EndoMT progression.
The decreased expression of endothelial differentiation factor VEGF, and the anti-fibrotic cytokine IL-10 42,43 in MP-depleted mice could also contribute to the inhibition of endothelial differentiation and further enhance the mesenchymal transition of endothelial-derived progenitors.
In conclusion, our results suggest that infiltrating MPs represent a relevant endogenous source of cytokines and angiogenic factors, which support neo-angiogenesis during muscle regeneration by both sustaining the differentiation of endothelial-derived progenitors toward an endothelial fate and by preventing the formation of a fibrotic scar. It is tempting to speculate that in pathogenic conditions, when failure of correct MP infiltration occurs, the fate of endothelial-derived progenitors can be skewed to a fibroblastic phenotype, further contributing to an abnormal tissue remodeling.
Although more studies will be necessary to elucidate in detail the molecular mechanisms that underlie EndoMT in the skeletal muscle, our findings open the possibility that endothelial cells in the muscle as well as MPs may represent new targets for therapeutic intervention for several devastating diseases such dystrophy and other genetic myopathies as well as in aging.
Materials and Methods
Mice. Transgenic mice have been previously described: Cdh5-CreER T2 ; 18 R26REYFP; 19 R26-NZG. 20 All procedures were performed in the animal facility of San Raffaele Scientific Institute in accordance with European Union guidelines and with the approval of the Institutional Ethical Committee (IACUC no. 489).
TAM injection. Cre recombination was induced in Cdh5-CreER T2 :R26R-EYFP or Cdh5-CreER T2 :R26-NZG mice at postnatal days 6-8 with three consecutive subcutaneus injections of TAM (25 ml Tam each, 10 mg/ml).
Muscle injury. Mice (4-6 mice per group) were anesthetized and subsequently injected with CTX in different muscles (Naja mossambica mossambica, Sigma-Aldrich (St. Louis, MO, USA); 50 ml, 15 mM for TA and triceps muscles, 50 mM for quadriceps muscles) and killed at 1, 3, 5, 7, 10, 15, 18 and 21 days after injury. For RNA analyses, muscles were snap frozen in liquid nitrogen. For histology, muscles were collected and embedded in OCT or directly frozen in liquid nitrogen cool isopentane.
Retrieval and purification of muscle-infiltrating MPs. Infiltrating cells were retrieved from damaged muscles 1, 3, 5, 7 and 10 days after sterile injury. Muscles were dissociated by enzymatic digestion with collagenase type V (0.5 mg/ml; Sigma-Aldrich) and dispase (3.5 mg/ml; Invitrogen, Carlsbad, CA, USA) at 37 1C for 40 min. Infiltrating cells were further purified by magnetic cell sorting using CD11b-conjugate beads (Milteny Biotec, Bergisch Gladbach, Germany) and processed for RNA extraction.
Depletion of circulating phagocytes. Mice were injected intravenously with 200 ml liposomes containing Cll (9 mg/ml) or PBS (sham) 1 day before CTX injection and every 3 days afterward (after 2, 5, 8, 11, 14, 17, 20 days after CTX injection). Cll were purchased from http://www.clodronateliposomes. org/ashwindigital.asp?docid=26.
RNA extraction and quantitative real-time PCR analysis. Total RNA was extracted from TA muscles, from purified muscle-infiltrating CD11b þ cells and from FACS sorted EYFP þ cells, using TRIzol reagent (Invitrogen), following the manufacturer's recommendations. Total RNA (1 mg) was reverse transcribed with random hexameric primers and MultiScribe reverse transcriptase (Applied Biosystems, Warrington, UK), as described. 22 cDNAs were quantified by real-time PCR on a MX 3000 apparatus (Stratagene, La Jolla, CA, USA) using specific primers (see below). PCR amplification was performed in a volume of 20 ml containing 1 ml cDNA, 100 nmol/l of each primer, 4 mmol/l MgCl2, the Brillant Quantitative PCR Core Reagent Kit mix and SYBR Green 0.333. IHC was performed on muscle sections fixed with 4% PFA treated with 0.3% H 2 O 2 and with an avidin-biotin blocking kit (Vector Laboratories, Burlingame, CA, USA), according to the manufacturer's instructions. Sections were blocked with 5% BSA, 0.1% Triton and 10% donkey serum in PBS for 1 h at RT. Subsequently, sections were incubated O/N with primary antibody anti-CD31 (1 : 2, clone MEC13.3, gift from E Dejana). Primary Ab was revealed using biotin-conjugated anti-rat (1 : 300) IgG (eBiosciences, San Diego, CA, USA) and HRP streptavidin (Vector Laboratories), and detected using Vector NovaRED substrate kit (Vector Laboratories). Specimens were counterstained with hematoxylin and examined with a Nikon Eclipse 55i microscope (Nikon, Tokyo, Japan). Parallel slides without primary Ab were identically processed and used as negative controls. The number and the area of CD31 þ capillaries were quantified using ImageJ software (NIH, Bethesda, MD, USA). Analysis was performed in serial transverse sections from the whole-muscle length.
For IF, muscle sections were fixed with a 4% PFA in PBS. They were permeabilized with a 0.2% Triton, 1% BSA solution in PBS for 30 min at RT and then blocked in 10% serum, 1% BSA solution in PBS for 30 min before incubation with primary antibodies: rabbit anti-mouse b-Gal (1 : 1500; MP Biomedicals, Illkirch, France); rabbit anti-mouse NG2 (1 : 300; Chemicon, Merck Millipore, Billerica, MA, USA); monoclonal anti-mouse CD31 (1 : 2; kind gift from E Dejana); SMA (1 : 200; Sigma-Aldrich); rabbit anti-mouse GFP (1 : 300; Invitrogen); rabbit phospho-Smad2/ 3 (Ser465/467) antibody #3101 (1 : 150; Cell Signalling, Davers, MA, USA); goat anti-mouse PDGFR-a (1 : 100; R&D Systems, Minneapolis, MN, USA); rat antimouse CD68 (1 : 150; AbD Serotec, Bio Rad, Hercules, CA, USA) to identify MP; rat anti-mouse CD206 (1 : 100; AbD Serotec), rabbit anti-mouse CD163 (1 : 200; Santa Cruz Biotechnology, Dallas, TX, USA) and rat anti-mouse CD86 (1 : 100; BD-Pharmingen, Franklin Lakes, NJ, USA) to identify different sub-population of MPs. Appropriate Alexa Fluor (Alexa 488, Alexa 594 or Alexa 546)-conjugated antibodies (1 : 500; Invitrogen) were used as second-step reagents. Specimens were counterstained with Hoechst 33342 (Molecular Probes, Life Technologies, Carlsbad, CA, USA) and analyzed using a Nikon microscope Eclipse E600. Image acquisition was done using the Nikon digital camera DXM1200 and the acquisition software Nikon ACT-1. Images showing double or multiple fluorescence were first acquired separately using appropriate filters, then the different layers were merged using Adobe Photoshop CS4. X-Gal staining was converted in pseudo-fluorescent colors by Adobe Photoshop.
TUNEL assay was performed on muscle sections from sham and Cll-treated mice 3 days after CTX injection using the In Situ Cell Death Detection Kit, TMR red (Roche, Basel, Switzerland), as described by the manufacturer.
Western blot. Total skeletal muscle or CD11b þ infiltrating cells were lysed in 10 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet P40, 0.1% sodium dodecyl sulfate (SDS), 10 mM EDTA and protease/phosphatase inhibitors cocktail (SigmaAldrich). Lysates were centrifuged at maximum speed for 15 min at 4 1C. For western blot analysis, equal amounts of protein (20 mg) were resolved by SDS polyacrylamide gel electrophoresis and transferred onto Immobilon-P (Merck Millipore). After Ponceau S (Sigma-Aldrich) staining, membranes were saturated in 20 mM Tris-HCl, pH 7.6, 150 mM NaCl (Tris-buffered saline) containing 2% non-fat milk and 0.1% Tween 20. Antigens were detected using the following antibodies: rabbit anti-mouse HIF1-a (Cayman Chemicals, Ann Arbor, MI, USA), mouse monoclonal anti-TGF-b (clone 1D11, Bio x cell, West Lebanon, NH, USA), mouse monoclonal anti-b-actin (Sigma-Aldrich), mouse monoclonal anti-GAPDH (SigmaAldrich). All antibodies were diluted in TBST 2% not-fat milk. Immunoreactive bands were revealed using an ECL detection kit (GE Healthcare Europe GmbH, Little Chalfont, UK).
Flow cytometry. EYFP þ endothelial-derived cells from Cdh5-CreER T2 :R26R-EYFP mice were isolated from P11, P60 or adult mice after muscle dissection. Tissues were cut in small pieces and dissociated with 0.1% collagenase D (Roche) and 0.25% Trypsin (Gibco, Life Technology) or 0.4 mg/ml Dispase (Gibco). Dissociation reaction was performed at 37 1C for 20 min for 2-3 cycles. Resuspended mononucleated cells were filtered with 70 and 40 mM filters. Cells were resuspended in either DMEM with 20% FBS, 20 mM HEPES, 2 mM EDTA or PBS with 2% FBS, 2 mM EDTA (for antibody staining). For FACS analyses on circulating cells, blood from tail or heart was retrieved, washed with red lysis buffer, incubated at 4 1C for 30 min in blocking solution (PBS with 2% FBS, 2 mM EDTA). Cell sorting was performed using the MoFLo system (DAKO, Glostrup, Denmark). FACS analysis was carried out using the BD FacsAccuri system (BD, Franklin Lakes, NJ, USA). Data were analyzed by FACSDIVA software (BD). The following antibodies were used for FACS analysis: rat anti-mouse CD45-PE (clone 30-F11, BD); rat anti-mouse CD45-PeCy7 (BD); rat anti-mouse CD31-PE (BD); unconjugated rabbit anti-mouse NG2 (Chemicon-Merck Millipore); anti-rat S/MC2.6 (kind gift from So-Ichiro Fukada) plus Streptavidine APC (BD-Pharmigen). When using unconjugated antibodies, primary antibody reaction was followed by secondary antibody donkey anti-rabbit Alexa Fluor 647.
Statistics. Differences between different experimental groups were evaluated by ANOVA analysis with Bonferroni as post hoc tests. Differences between only two experimental groups were compared by Student's t-test. Statistical significance was accepted for comparisons where Po0.05. Values presented are means ± S.E.M.
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